1. Home
  2. ZBAO vs IVVD Comparison

ZBAO vs IVVD Comparison

Compare ZBAO & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBAO
  • IVVD
  • Stock Information
  • Founded
  • ZBAO 2015
  • IVVD 2020
  • Country
  • ZBAO China
  • IVVD United States
  • Employees
  • ZBAO N/A
  • IVVD N/A
  • Industry
  • ZBAO
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZBAO
  • IVVD Health Care
  • Exchange
  • ZBAO NYSE
  • IVVD Nasdaq
  • Market Cap
  • ZBAO 104.7M
  • IVVD 116.8M
  • IPO Year
  • ZBAO 2024
  • IVVD 2021
  • Fundamental
  • Price
  • ZBAO $3.00
  • IVVD $0.70
  • Analyst Decision
  • ZBAO
  • IVVD Strong Buy
  • Analyst Count
  • ZBAO 0
  • IVVD 5
  • Target Price
  • ZBAO N/A
  • IVVD $7.11
  • AVG Volume (30 Days)
  • ZBAO 6.1K
  • IVVD 581.2K
  • Earning Date
  • ZBAO 12-03-2024
  • IVVD 11-14-2024
  • Dividend Yield
  • ZBAO N/A
  • IVVD N/A
  • EPS Growth
  • ZBAO N/A
  • IVVD N/A
  • EPS
  • ZBAO 0.06
  • IVVD N/A
  • Revenue
  • ZBAO $25,274,784.00
  • IVVD $11,564,000.00
  • Revenue This Year
  • ZBAO $65.08
  • IVVD N/A
  • Revenue Next Year
  • ZBAO $34.27
  • IVVD $72.22
  • P/E Ratio
  • ZBAO $49.96
  • IVVD N/A
  • Revenue Growth
  • ZBAO 29.25
  • IVVD N/A
  • 52 Week Low
  • ZBAO $2.36
  • IVVD $0.71
  • 52 Week High
  • ZBAO $5.70
  • IVVD $5.20
  • Technical
  • Relative Strength Index (RSI)
  • ZBAO N/A
  • IVVD 33.40
  • Support Level
  • ZBAO N/A
  • IVVD $0.72
  • Resistance Level
  • ZBAO N/A
  • IVVD $0.81
  • Average True Range (ATR)
  • ZBAO 0.00
  • IVVD 0.07
  • MACD
  • ZBAO 0.00
  • IVVD -0.02
  • Stochastic Oscillator
  • ZBAO 0.00
  • IVVD 1.12

About ZBAO ZHIBAO TECHNOLOGY INC

Zhibao Technology Inc is a insurance technology company primarily engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their innovative business model which They pioneered in China. They provide customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: